{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:01:57Z","timestamp":1791820917801,"version":"4.3.4"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02084-7","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:58:35Z","timestamp":1760720315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Interleukin 15 and autoimmune disorders: pathophysiology, therapeutic potential, and clinical implications"],"prefix":"10.1007","volume":"74","author":[{"given":"Leila","family":"Darouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tavassoli Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Orooji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Shadab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniyeh","family":"Molavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Haghmorad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"3","key":"2084_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","volume":"2","author":"GS Cooper","year":"2003","unstructured":"Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119\u201325.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2084_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","volume":"181","author":"L Fugger","year":"2020","unstructured":"Fugger L, Jensen LT, Rossjohn J. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell. 2020;181(1):63\u201380.","journal-title":"Cell"},{"key":"2084_CR3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116744","volume":"233","author":"R Illescas-Montes","year":"2019","unstructured":"Illescas-Montes R, et al. Vitamin D and autoimmune diseases. Life Sci. 2019;233: 116744.","journal-title":"Life Sci"},{"key":"2084_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.982238","author":"D-K Xiong","year":"2022","unstructured":"Xiong D-K, et al. The regulatory mechanism and potential application of IL-23 in autoimmune diseases. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.982238.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2084_CR5","first-page":"25","volume":"19","author":"GH Ring","year":"1999","unstructured":"Ring GH, Lakkis FG. Breakdown of self-tolerance and the pathogenesis of autoimmunity. Semin Nephrol. 1999;19(1):25\u201333.","journal-title":"Semin Nephrol"},{"issue":"2","key":"2084_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103236","volume":"22","author":"K Bieber","year":"2023","unstructured":"Bieber K, et al. Autoimmune pre-disease. Autoimmun Rev. 2023;22(2): 103236.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"2084_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi M, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9(1):176.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2084_CR8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmrp.2015.07.002","volume":"5","author":"S Kakar","year":"2015","unstructured":"Kakar S. Cytokines evolution: role in various diseases. Curr Med Res Pract. 2015;5(4):176\u201382.","journal-title":"Curr Med Res Pract"},{"key":"2084_CR9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155258","volume":"136","author":"H Allard-Chamard","year":"2020","unstructured":"Allard-Chamard H, et al. Interleukin-15 in autoimmunity. Cytokine. 2020;136: 155258.","journal-title":"Cytokine"},{"issue":"1","key":"2084_CR10","doi-asserted-by":"crossref","DOI":"10.1093\/discim\/kyae002","volume":"3","author":"N Skariah","year":"2024","unstructured":"Skariah N, James OJ, Swamy M. Signalling mechanisms driving homeostatic and inflammatory effects of interleukin-15 on tissue lymphocytes. Discov Immunol. 2024;3(1): kyae002.","journal-title":"Discov Immunol"},{"issue":"13","key":"2084_CR11","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.3390\/ijms23137311","volume":"23","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, et al. Interleukin 15 in cell-based cancer immunotherapy. Int J Mol Sci. 2022;23(13):7311.","journal-title":"Int J Mol Sci"},{"key":"2084_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1184703","author":"M Cai","year":"2023","unstructured":"Cai M, et al. Research progress of interleukin-15 in cancer immunotherapy. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1184703.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2084_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tips.2011.09.004","volume":"33","author":"JC Steel","year":"2012","unstructured":"Steel JC, Waldmann TA, Morris JC. Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci. 2012;33(1):35\u201341.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"2084_CR14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.humimm.2015.09.041","volume":"76","author":"X-K Yang","year":"2015","unstructured":"Yang X-K, et al. Therapeutic potential of IL-15 in rheumatoid arthritis. Hum Immunol. 2015;76(11):812\u20138.","journal-title":"Hum Immunol"},{"issue":"3","key":"2084_CR15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF01540911","volume":"16","author":"MK Kennedy","year":"1996","unstructured":"Kennedy MK, Park LS. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol. 1996;16(3):134\u201343.","journal-title":"J Clin Immunol"},{"issue":"3","key":"2084_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/2326-6066.CIR-15-0009","volume":"3","author":"TA Waldmann","year":"2015","unstructured":"Waldmann TA. The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res. 2015;3(3):219\u201327.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"2084_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cytogfr.2013.05.004","volume":"24","author":"D Pagliari","year":"2013","unstructured":"Pagliari D, et al. The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev. 2013;24(5):455\u201366.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2084_CR18","doi-asserted-by":"crossref","first-page":"1141208","DOI":"10.3389\/fimmu.2023.1141208","volume":"14","author":"P Sindaco","year":"2023","unstructured":"Sindaco P, et al. The role of interleukin-15 in the development and treatment of hematological malignancies. Front Immunol. 2023;14:1141208.","journal-title":"Front Immunol"},{"issue":"3","key":"2084_CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.micinf.2011.10.006","volume":"14","author":"PY Perera","year":"2012","unstructured":"Perera PY, et al. The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect. 2012;14(3):247\u201361.","journal-title":"Microbes Infect"},{"issue":"1","key":"2084_CR20","volume":"24","author":"H Lee","year":"2024","unstructured":"Lee H, Park S-H, Shin E-C. IL-15 in T-cell responses and immunopathogenesis. Immune Netw. 2024;24(1): e11.","journal-title":"Immune Netw"},{"issue":"2","key":"2084_CR21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/cei\/uxae038","volume":"217","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. NK-like CD8 T cell: one potential evolutionary continuum between adaptive memory and innate immunity. Clin Exp Immunol. 2024;217(2):136\u201350.","journal-title":"Clin Exp Immunol"},{"key":"2084_CR22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191062","author":"TA Waldmann","year":"2020","unstructured":"Waldmann TA, Miljkovic MD, Conlon KC. Interleukin-15 (dys)regulation of lymphoid homeostasis: implications for therapy of autoimmunity and cancer. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191062.","journal-title":"J Exp Med"},{"issue":"1","key":"2084_CR23","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/s41598-020-80507-7","volume":"11","author":"R Pandey","year":"2021","unstructured":"Pandey R, et al. Role of subnetworks mediated by TNF \u03b1, IL-23\/IL-17 and IL-15 in a network involved in the pathogenesis of psoriasis. Sci Rep. 2021;11(1):2204.","journal-title":"Sci Rep"},{"issue":"3","key":"2084_CR24","volume":"9","author":"J Lu","year":"2020","unstructured":"Lu J, et al. Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets. Clin Transl Immunol. 2020;9(3): e1122.","journal-title":"Clin Transl Immunol"},{"key":"2084_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","volume":"38","author":"Y Guo","year":"2017","unstructured":"Guo Y, et al. Immunobiology of the IL-15\/IL-15R\u03b1 complex as an antitumor and antiviral agent. Cytokine Growth Factor Rev. 2017;38:10\u201321.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2084_CR26","volume":"91","author":"S Zhang","year":"2021","unstructured":"Zhang S, et al. Biological effects of IL-15 on immune cells and its potential for the treatment of cancer. Int Immunopharmacol. 2021;91: 107318.","journal-title":"Int Immunopharmacol"},{"key":"2084_CR27","doi-asserted-by":"crossref","unstructured":"Schluns K, Anthony S Emerging roles for IL-15 in the activation and function of T-cells during immune stimulation. Research and Reports in Biology, 2015","DOI":"10.2147\/RRB.S57685"},{"key":"2084_CR28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00571","volume":"6","author":"CA Roberts","year":"2015","unstructured":"Roberts CA, Dickinson AK, Taams LS. The interplay between monocytes\/macrophages and CD4+ T cell subsets in rheumatoid arthritis. Front Immunol. 2015;6: 571.","journal-title":"Front Immunol"},{"issue":"7","key":"2084_CR29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212391","volume":"219","author":"CE Whyte","year":"2022","unstructured":"Whyte CE, et al. Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits. J Exp Med. 2022;219(7): e20212391.","journal-title":"J Exp Med"},{"issue":"12","key":"2084_CR30","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.3390\/cancers12123586","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang Y, Lundqvist A. Immunomodulatory effects of IL-2 and IL-15; implications for cancer immunotherapy. Cancers. 2020;12(12):3586.","journal-title":"Cancers"},{"key":"2084_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109438","author":"I-H Seo","year":"2021","unstructured":"Seo I-H, et al. IL-15 enhances CCR5-mediated migration of memory CD8+ T cells by upregulating CCR5 expression in the absence of TCR stimulation. Cell Rep. 2021. https:\/\/doi.org\/10.1016\/j.celrep.2021.109438.","journal-title":"Cell Rep"},{"issue":"1","key":"2084_CR32","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e11","volume":"23","author":"J Seok","year":"2023","unstructured":"Seok J, et al. Roles of virtual memory T cells in diseases. Immune Netw. 2023;23(1): e11.","journal-title":"Immune Netw"},{"key":"2084_CR33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594620","volume":"11","author":"F Watkinson","year":"2021","unstructured":"Watkinson F, et al. IL-15 upregulates telomerase expression and potently increases proliferative capacity of NK, NKT-like, and CD8 T cells. Front Immunol. 2021;11: 594620.","journal-title":"Front Immunol"},{"key":"2084_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.610789","author":"X Wang","year":"2021","unstructured":"Wang X, Zhao X-Y. Transcription factors associated with IL-15 cytokine signaling during NK cell development. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.610789.","journal-title":"Front Immunol"},{"issue":"1","key":"2084_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cyto.2008.01.003","volume":"42","author":"C Zhang","year":"2008","unstructured":"Zhang C, et al. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1\/2 phosphorylation. Cytokine. 2008;42(1):128\u201336.","journal-title":"Cytokine"},{"issue":"12","key":"2084_CR36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/ni729","volume":"2","author":"T Ohteki","year":"2001","unstructured":"Ohteki T, et al. Critical role of IL-15\u2013IL-15R for antigen-presenting cell functions in the innate immune response. Nat Immunol. 2001;2(12):1138\u201343.","journal-title":"Nat Immunol"},{"issue":"3","key":"2084_CR37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2249.2001.01672.x","volume":"126","author":"KU Saikh","year":"2001","unstructured":"Saikh KU, et al. IL-15-induced conversion of monocytes to mature dendritic cells. Clin Exp Immunol. 2001;126(3):447\u201355.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2084_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/imr.12191","volume":"260","author":"V Abadie","year":"2014","unstructured":"Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev. 2014;260(1):221\u201334.","journal-title":"Immunol Rev"},{"key":"2084_CR39","doi-asserted-by":"crossref","unstructured":"Waldmann TA The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders. In Journal of Investigative Dermatology Symposium Proceedings. 2013","DOI":"10.1038\/jidsymp.2013.8"},{"issue":"21","key":"2084_CR40","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.200363097","volume":"97","author":"J Marks-Konczalik","year":"2000","unstructured":"Marks-Konczalik J, et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A. 2000;97(21):11445\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2084_CR41","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.1201620","volume":"190","author":"P Deshpande","year":"2013","unstructured":"Deshpande P, et al. IL-7\u2013and IL-15\u2013mediated TCR sensitization enables T cell responses to self-antigens. J Immunol. 2013;190(4):1416\u201323.","journal-title":"J Immunol"},{"issue":"8","key":"2084_CR42","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.2337\/db11-1547","volume":"61","author":"BM Schulte","year":"2012","unstructured":"Schulte BM, et al. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes. 2012;61(8):2030\u20136.","journal-title":"Diabetes"},{"issue":"1","key":"2084_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2010.09.003","volume":"22","author":"A Di Sabatino","year":"2011","unstructured":"Di Sabatino A, et al. Role of IL-15 in immune-mediated and infectious diseases. Cytokine Growth Factor Rev. 2011;22(1):19\u201333.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"2084_CR44","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.20020369","volume":"195","author":"TC Becker","year":"2002","unstructured":"Becker TC, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 2002;195(12):1541\u20138.","journal-title":"J Exp Med"},{"issue":"10","key":"2084_CR45","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, et al. A human memory T cell subset with stem cell\u2013like properties. Nat Med. 2011;17(10):1290\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"2084_CR46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imr.13206","volume":"316","author":"P Laphanuwat","year":"2023","unstructured":"Laphanuwat P, Gomes DCO, Akbar AN. Senescent T cells: beneficial and detrimental roles. Immunol Rev. 2023;316(1):160\u201375.","journal-title":"Immunol Rev"},{"issue":"11","key":"2084_CR47","volume":"5","author":"SR Morris","year":"2020","unstructured":"Morris SR, et al. Inflammescent CX3CR1+ CD57+ CD8+ T cells are generated and expanded by IL-15. JCI Insight. 2020;5(11): e132963.","journal-title":"JCI Insight"},{"issue":"26","key":"2084_CR48","doi-asserted-by":"crossref","first-page":"E5980","DOI":"10.1073\/pnas.1720564115","volume":"115","author":"MP Correia","year":"2018","unstructured":"Correia MP, et al. Distinct human circulating NKp30+ Fc\u03b5RI\u03b3+ CD8+ T cell population exhibiting high natural killer-like antitumor potential. Proc Natl Acad Sci U S A. 2018;115(26):E5980\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2084_CR49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nri.2017.34","volume":"17","author":"JT White","year":"2017","unstructured":"White JT, Cross EW, Kedl RM. Antigen-inexperienced memory CD8+ T cells: Where they come from and why we need them. Nat Rev Immunol. 2017;17(6):391\u2013400.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2084_CR50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.celrep.2018.08.094","volume":"25","author":"LE Holz","year":"2018","unstructured":"Holz LE, et al. CD8+ T cell activation leads to constitutive formation of liver tissue-resident memory T cells that seed a large and flexible niche in the liver. Cell Rep. 2018;25(1):68\u201379.","journal-title":"Cell Rep"},{"issue":"9","key":"2084_CR51","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.4049\/jimmunol.1502337","volume":"196","author":"JM Schenkel","year":"2016","unstructured":"Schenkel JM, et al. IL-15\u2013independent maintenance of tissue-resident and boosted effector memory CD8 T cells. J Immunol. 2016;196(9):3920\u20136.","journal-title":"J Immunol"},{"issue":"4","key":"2084_CR52","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jhep.2022.05.020","volume":"77","author":"J-Y Koh","year":"2022","unstructured":"Koh J-Y, et al. Identification of a distinct NK-like hepatic T-cell population activated by NKG2C in a TCR-independent manner. J Hepatol. 2022;77(4):1059\u201370.","journal-title":"J Hepatol"},{"issue":"6","key":"2084_CR53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41568-023-00562-w","volume":"23","author":"B Ruf","year":"2023","unstructured":"Ruf B, Greten TF, Korangy F. Innate lymphoid cells and innate-like T cells in cancer: at the crossroads of innate and adaptive immunity. Nat Rev Cancer. 2023;23(6):351\u201371.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2084_CR54","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41467-021-22162-8","volume":"12","author":"H Tao","year":"2021","unstructured":"Tao H, et al. Differential controls of MAIT cell effector polarization by mTORC1\/mTORC2 via integrating cytokine and costimulatory signals. Nat Commun. 2021;12(1):2029.","journal-title":"Nat Commun"},{"issue":"1","key":"2084_CR55","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1038\/ncomms11653","volume":"7","author":"B Van Wilgenburg","year":"2016","unstructured":"Van Wilgenburg B, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7(1):11653.","journal-title":"Nat Commun"},{"issue":"1","key":"2084_CR56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41420-022-00942-5","volume":"8","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Interleukin-15 enhanced the survival of human \u03b3\u03b4T cells by regulating the expression of Mcl-1 in neuroblastoma. Cell Death Discov. 2022;8(1):139.","journal-title":"Cell Death Discov"},{"issue":"5","key":"2084_CR57","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s10753-023-01860-z","volume":"46","author":"T Wang","year":"2023","unstructured":"Wang T, et al. Coordinated priming of NKG2D pathway by IL-15 enhanced functional properties of cytotoxic CD4+ CD28\u2212 T cells expanded in systemic lupus erythematosus. Inflammation. 2023;46(5):1587\u2013601.","journal-title":"Inflammation"},{"issue":"4","key":"2084_CR58","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cytogfr.2006.05.001","volume":"17","author":"V Budagian","year":"2006","unstructured":"Budagian V, et al. IL-15\/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17(4):259\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2084_CR59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2016.11.003","volume":"77","author":"Y Chen","year":"2017","unstructured":"Chen Y, et al. Interleukin-7 and-15 maintain pathogenic memory Th17 cells in autoimmunity. J Autoimmun. 2017;77:96\u2013103.","journal-title":"J Autoimmun"},{"key":"2084_CR60","volume":"129","author":"N-W Fan","year":"2022","unstructured":"Fan N-W, et al. Autoreactive memory Th17 cells are principally derived from T-bet+ ROR\u03b3t+ Th17\/1 effectors. J Autoimmun. 2022;129: 102816.","journal-title":"J Autoimmun"},{"key":"2084_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-015-0516-3","volume":"16","author":"A Santos Savio","year":"2015","unstructured":"Santos Savio A, et al. Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients. BMC Musculoskelet Disord. 2015;16:1\u20138.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"2084_CR62","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/cmi.2015.102","volume":"14","author":"D Bobbala","year":"2017","unstructured":"Bobbala D, et al. Trans-presentation of interleukin-15 by interleukin-15 receptor alpha is dispensable for the pathogenesis of autoimmune type 1 diabetes. Cell Mol Immunol. 2017;14(7):590\u20136.","journal-title":"Cell Mol Immunol"},{"key":"2084_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01603","author":"K Sestak","year":"2018","unstructured":"Sestak K, et al. Beneficial effects of human anti-interleukin-15 antibody in gluten-sensitive rhesus macaques with celiac disease. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01603.","journal-title":"Front Immunol"},{"issue":"10","key":"2084_CR64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11926-019-0856-3","volume":"21","author":"SJ Pedersen","year":"2019","unstructured":"Pedersen SJ, Maksymowych WP. The pathogenesis of ankylosing spondylitis: an update. Curr Rheumatol Rep. 2019;21(10):58.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"2084_CR65","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.1301000","volume":"191","author":"H Lebrec","year":"2013","unstructured":"Lebrec H, et al. Homeostasis of human NK cells is not IL-15 dependent. J Immunol. 2013;191(11):5551\u20138.","journal-title":"J Immunol"},{"issue":"24","key":"2084_CR66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413501","volume":"25","author":"A Bojarczuk","year":"2024","unstructured":"Bojarczuk A, et al. Systematic review of IL-1, IL-4, IL-6, IL-10, IL-15, and IL-18 gene polymorphisms and meta-analysis of IL-6 variant and its association with overweight and obesity risk in men. Int J Mol Sci. 2024;25(24): 13501.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2084_CR67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","volume":"385","author":"D Schuppan","year":"2021","unstructured":"Schuppan D, et al. A randomized trial of a transglutaminase 2 inhibitor for celiac disease. N Engl J Med. 2021;385(1):35\u201345.","journal-title":"N Engl J Med"},{"key":"2084_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886213","author":"D Meghnem","year":"2022","unstructured":"Meghnem D, et al. Selective targeting of IL-15R\u03b1 is sufficient to reduce inflammation. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.886213.","journal-title":"Front Immunol"},{"issue":"1","key":"2084_CR69","doi-asserted-by":"crossref","first-page":"e931","DOI":"10.1212\/NXI.0000000000000931","volume":"8","author":"C Laurent","year":"2020","unstructured":"Laurent C, et al. Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE. Neurol Neuroimmunol Neuroinflammation. 2020;8(1):e931.","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"1","key":"2084_CR70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12979-022-00305-9","volume":"19","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. Excessive IL-15 promotes cytotoxic CD4+ CD28\u2212 T cell-mediated renal injury in lupus nephritis. Immunity Ageing. 2022;19(1):50.","journal-title":"Immunity Ageing"},{"issue":"5","key":"2084_CR71","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ar.25044","volume":"306","author":"AM Kautzman","year":"2023","unstructured":"Kautzman AM, et al. Interleukin 15 in murine models of colitis. Anat Rec (Hoboken). 2023;306(5):1111\u201330.","journal-title":"Anat Rec (Hoboken)"},{"issue":"4","key":"2084_CR72","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/03008207.2016.1177036","volume":"57","author":"Y Wei","year":"2016","unstructured":"Wei Y, Bai L. Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis. Connect Tissue Res. 2016;57(4):245\u201361.","journal-title":"Connect Tissue Res"},{"key":"2084_CR73","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3389\/fimmu.2020.01385","volume":"11","author":"SC Warner","year":"2020","unstructured":"Warner SC, et al. IL-15 and IL15RA in osteoarthritis: association with symptoms and protease production, but not structural severity. Front Immunol. 2020;11:1385.","journal-title":"Front Immunol"},{"issue":"4","key":"2084_CR74","first-page":"3377","volume":"16","author":"Y Jin","year":"2018","unstructured":"Jin Y, et al. Expression levels of IL-15 and IL-17 in synovial fluid of rheumatoid arthritis animal model. Exp Ther Med. 2018;16(4):3377\u201382.","journal-title":"Exp Ther Med"},{"issue":"5","key":"2084_CR75","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/jcm14051735","volume":"14","author":"M Colina","year":"2025","unstructured":"Colina M, Campana G. Precision medicine in rheumatology: the role of biomarkers in diagnosis and treatment optimization. J Clin Med. 2025;14(5):1735.","journal-title":"J Clin Med"},{"key":"2084_CR76","doi-asserted-by":"crossref","first-page":"1183535","DOI":"10.3389\/fmed.2023.1183535","volume":"10","author":"KA Fenton","year":"2023","unstructured":"Fenton KA, Pedersen HL. Advanced methods and novel biomarkers in autoimmune diseases: a review of the recent years progress in systemic lupus erythematosus. Front Med. 2023;10:1183535.","journal-title":"Front Med"},{"issue":"12","key":"2084_CR77","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/jir.2011.0094","volume":"31","author":"B Astry","year":"2011","unstructured":"Astry B, Harberts E, Moudgil KD. A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res. 2011;31(12):927\u201340.","journal-title":"J Interferon Cytokine Res"},{"issue":"8","key":"2084_CR78","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/cells8080898","volume":"8","author":"A Alunno","year":"2019","unstructured":"Alunno A, et al. Pathogenic and therapeutic relevance of JAK\/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition with an oral agent. Cells. 2019;8(8):898.","journal-title":"Cells"},{"issue":"4","key":"2084_CR79","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/ijms23042106","volume":"23","author":"OM Koper-Lenkiewicz","year":"2022","unstructured":"Koper-Lenkiewicz OM, et al. Proinflammatory cytokines (IL-1,-6,-8,-15,-17,-18,-23, TNF-\u03b1) single nucleotide polymorphisms in rheumatoid arthritis: a literature review. Int J Mol Sci. 2022;23(4):2106.","journal-title":"Int J Mol Sci"},{"key":"2084_CR80","volume":"11","author":"JD Piganelli","year":"2020","unstructured":"Piganelli JD, Mamula MJ, James EA. The role of \u03b2 cell stress and neo-epitopes in the immunopathology of type 1 diabetes. Front Endocrinol (Lausanne). 2020;11: 624590.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2084_CR81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.622306","volume":"12","author":"UC Kucuksezer","year":"2021","unstructured":"Kucuksezer UC, et al. The role of natural killer cells in autoimmune diseases. Front Immunol. 2021;12: 622306.","journal-title":"Front Immunol"},{"key":"2084_CR82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1141208","volume":"14","author":"P Sindaco","year":"2023","unstructured":"Sindaco P, et al. The role of interleukin-15 in the development and treatment of hematological malignancies. Front Immunol. 2023;14: 1141208.","journal-title":"Front Immunol"},{"issue":"2","key":"2084_CR83","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.4049\/jimmunol.175.2.1248","volume":"175","author":"CE Mathews","year":"2005","unstructured":"Mathews CE, et al. Mechanisms underlying resistance of pancreatic islets from ALR\/Lt mice to cytokine-induced destruction1. J Immunol. 2005;175(2):1248\u201356.","journal-title":"J Immunol"},{"issue":"1","key":"2084_CR84","volume":"12","author":"OJ James","year":"2021","unstructured":"James OJ, et al. IL-15 and PIM kinases direct the metabolic programming of intestinal intraepithelial lymphocytes. Nat Commun. 2021;12(1): 4290.","journal-title":"Nat Commun"},{"issue":"1","key":"2084_CR85","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/er.2017-00167","volume":"39","author":"A Ardestani","year":"2017","unstructured":"Ardestani A, Maedler K. The hippo signaling pathway in pancreatic \u03b2-cells: functions and regulations. Endocr Rev. 2017;39(1):21\u201335.","journal-title":"Endocr Rev"},{"issue":"1","key":"2084_CR86","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz P, Poniatowski \u0141A, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014;2014(1): 561459.","journal-title":"Mediators Inflamm"},{"key":"2084_CR87","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1076343","volume":"14","author":"S Dalle","year":"2023","unstructured":"Dalle S, Abderrahmani A, Renard E. Pharmacological inhibitors of \u03b2-cell dysfunction and death as therapeutics for diabetes. Front Endocrinol (Lausanne). 2023;14: 1076343.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2084_CR88","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1210\/en.2003-0754","volume":"145","author":"P Augstein","year":"2004","unstructured":"Augstein P, et al. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice. Endocrinology. 2004;145(6):2747\u201352.","journal-title":"Endocrinology"},{"issue":"2","key":"2084_CR89","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001428","volume":"8","author":"PF Fiore","year":"2020","unstructured":"Fiore PF, et al. Interleukin-15 and cancer: some solved and many unsolved questions. J Immunother Cancer. 2020;8(2): e001428.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"2084_CR90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nri3919","volume":"15","author":"B Jabri","year":"2015","unstructured":"Jabri B, Abadie V. IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat Rev Immunol. 2015;15(12):771\u201383.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2084_CR91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/gastro\/gou065","volume":"3","author":"NE Castillo","year":"2014","unstructured":"Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol Rep. 2014;3(1):3\u201311.","journal-title":"Gastroenterol Rep"},{"issue":"20","key":"2084_CR92","volume":"24","author":"YS Patt","year":"2023","unstructured":"Patt YS, et al. Unraveling the immunopathological landscape of celiac disease: a comprehensive review. Int J Mol Sci. 2023;24(20): 15482.","journal-title":"Int J Mol Sci"},{"key":"2084_CR93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674313","volume":"12","author":"J Voisine","year":"2021","unstructured":"Voisine J, Abadie V. Interplay between gluten, HLA, innate and adaptive immunity orchestrates the development of coeliac disease. Front Immunol. 2021;12: 674313.","journal-title":"Front Immunol"},{"issue":"4","key":"2084_CR94","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","volume":"55","author":"A Di Sabatino","year":"2006","unstructured":"Di Sabatino A. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut. 2006;55(4):469\u201377.","journal-title":"Gut"},{"issue":"8","key":"2084_CR95","volume":"13","author":"Z Ren","year":"2021","unstructured":"Ren Z, et al. Gut microbiota-CRAMP axis shapes intestinal barrier function and immune responses in dietary gluten-induced enteropathy. EMBO Mol Med. 2021;13(8): e14059.","journal-title":"EMBO Mol Med"},{"issue":"13","key":"2084_CR96","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.3390\/ijms23137177","volume":"23","author":"MV Barone","year":"2022","unstructured":"Barone MV, et al. Pivotal role of inflammation in celiac disease. Int J Mol Sci. 2022;23(13):7177.","journal-title":"Int J Mol Sci"},{"key":"2084_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cells12141910","author":"A Rizzi","year":"2023","unstructured":"Rizzi A, et al. The emerging role of innate lymphoid cells (ILCs) and alarmins in celiac disease: an update on pathophysiological insights, potential use as disease biomarkers, and therapeutic implications. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12141910.","journal-title":"Cells"},{"issue":"1","key":"2084_CR98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10735-023-10175-0","volume":"55","author":"T Taraz","year":"2024","unstructured":"Taraz T, et al. Overview of the compromised mucosal integrity in celiac disease. J Mol Histol. 2024;55(1):15\u201324.","journal-title":"J Mol Histol"},{"key":"2084_CR99","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156277","volume":"169","author":"P Le\u015bnik","year":"2023","unstructured":"Le\u015bnik P, et al. Interleukin-7 and interleukin-15 as prognostic biomarkers in sepsis and septic shock: correlation with inflammatory markers and mortality. Cytokine. 2023;169: 156277.","journal-title":"Cytokine"},{"issue":"8","key":"2084_CR100","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.4049\/jimmunol.1701614","volume":"200","author":"HR Wagstaffe","year":"2018","unstructured":"Wagstaffe HR, et al. IL-15 promotes polyfunctional NK cell responses to influenza by boosting IL-12 production. J Immunol. 2018;200(8):2738\u201347.","journal-title":"J Immunol"},{"issue":"2","key":"2084_CR101","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41385-018-0118-0","volume":"12","author":"LMM Costes","year":"2019","unstructured":"Costes LMM, et al. IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine. Mucosal Immunol. 2019;12(2):479\u201390.","journal-title":"Mucosal Immunol"},{"key":"2084_CR102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/JIR.S93797","volume":"10","author":"EC Meszaros","year":"2017","unstructured":"Meszaros EC, Malemud CJ. Phosphorylation of STAT proteins by recombinant human IL-6 in immortalized human chondrocyte cell lines, T\/C28a2 and C28\/I2. J Inflamm Res. 2017;10:143\u201350.","journal-title":"J Inflamm Res"},{"key":"2084_CR103","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028449","author":"JX Lin","year":"2018","unstructured":"Lin JX, Leonard WJ. The common cytokine receptor \u03b3 chain family of cytokines. Cold Spring Harb Perspect Biol. 2018. https:\/\/doi.org\/10.1101\/cshperspect.a028449.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2084_CR104","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108946","volume":"216","author":"X Yang","year":"2022","unstructured":"Yang X, et al. Sulforaphane inhibits cytokine-stimulated chemokine and adhesion molecule expressions in human corneal fibroblasts: involvement of the MAPK, STAT, and NF-\u03baB signaling pathways. Exp Eye Res. 2022;216: 108946.","journal-title":"Exp Eye Res"},{"issue":"6","key":"2084_CR105","first-page":"E980","volume":"114","author":"YM Kooy-Winkelaar","year":"2017","unstructured":"Kooy-Winkelaar YM, et al. CD4 t-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes. Proc Natl Acad Sci U S A. 2017;114(6):E980-e989.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2084_CR106","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med. 2021;21(3):170\u20133.","journal-title":"Clin Med"},{"key":"2084_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-025-01778-y","author":"A Sharma","year":"2025","unstructured":"Sharma A, et al. PDE4 inhibitors in psoriasis therapy: current insights and future directions. Inflammopharmacology. 2025. https:\/\/doi.org\/10.1007\/s10787-025-01778-y.","journal-title":"Inflammopharmacology"},{"issue":"2","key":"2084_CR108","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/pcmedi\/pbz011","volume":"2","author":"D Ran","year":"2019","unstructured":"Ran D, Cai M, Zhang X. Genetics of psoriasis: a basis for precision medicine. Precis Clin Med. 2019;2(2):120\u201330.","journal-title":"Precis Clin Med"},{"issue":"2","key":"2084_CR109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The immunology of psoriasis\u2014current concepts in pathogenesis. Clin Rev Allergy Immunol. 2024;66(2):164\u201391.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"2084_CR110","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250279","volume":"54","author":"X Wang","year":"2024","unstructured":"Wang X, Lai Y. Keratinocytes in the pathogenesis, phenotypic switch, and relapse of psoriasis. Eur J Immunol. 2024;54(5): 2250279.","journal-title":"Eur J Immunol"},{"key":"2084_CR111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.ai.2022.09.002","volume":"156","author":"TA Waldmann","year":"2022","unstructured":"Waldmann TA, et al. The implications of IL-15 trans-presentation on the immune response. Adv Immunol. 2022;156:103\u201332.","journal-title":"Adv Immunol"},{"issue":"82","key":"2084_CR112","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add8454","volume":"8","author":"R Tieu","year":"2023","unstructured":"Tieu R, et al. Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15. Sci Immunol. 2023;8(82): eadd8454.","journal-title":"Sci Immunol"},{"key":"2084_CR113","doi-asserted-by":"crossref","unstructured":"Golob JG et al., IL-15 promotes inflammatory Th17 cells in the intestine. bioRxiv, 2023: p. 2023.03. 11.532227.","DOI":"10.1101\/2023.03.11.532227"},{"issue":"5","key":"2084_CR114","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5114\/ada.2016.62838","volume":"33","author":"A Lesiak","year":"2016","unstructured":"Lesiak A, et al. Are interleukin-15 and-22 a new pathogenic factor in pustular palmoplantar psoriasis? Adv Dermatol Allergol. 2016;33(5):336\u20139.","journal-title":"Adv Dermatol Allergol"},{"issue":"10","key":"2084_CR115","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1084\/jem.20130291","volume":"210","author":"G Bouchaud","year":"2013","unstructured":"Bouchaud G, et al. Epidermal IL-15R\u03b1 acts as an endogenous antagonist of psoriasiform inflammation in mouse and man. J Exp Med. 2013;210(10):2105\u201317.","journal-title":"J Exp Med"},{"issue":"10","key":"2084_CR116","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/diagnostics14100969","volume":"14","author":"M Negrutiu","year":"2024","unstructured":"Negrutiu M, et al. Imaging approach in the diagnostics and evaluation of the psoriasis plaque: a preliminary study and literature review. Diagnostics. 2024;14(10):969.","journal-title":"Diagnostics"},{"key":"2084_CR117","doi-asserted-by":"crossref","unstructured":"Majeed MW et al., CRF1 receptor antagonists in congenital adrenal hyperplasia: a systematic review and meta-analysis of phase 2 open label trials and phase 3 clinical trials. Endocrine and Metabolic Science, 2025: p. 100247.","DOI":"10.1016\/j.endmts.2025.100247"},{"key":"2084_CR118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886213","volume":"13","author":"D Meghnem","year":"2022","unstructured":"Meghnem D, et al. Selective targeting of IL-15R\u03b1 is sufficient to reduce inflammation. Front Immunol. 2022;13: 886213.","journal-title":"Front Immunol"},{"issue":"9","key":"2084_CR119","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.3390\/ijms25094681","volume":"25","author":"AR Furtunescu","year":"2024","unstructured":"Furtunescu AR, et al. Inhibition of the JAK-STAT pathway in the treatment of psoriasis: a review of the literature. Int J Mol Sci. 2024;25(9):4681.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2084_CR120","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jid.2008.308","volume":"129","author":"KC Duffin","year":"2009","unstructured":"Duffin KC, Krueger GG. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. J Invest Dermatol. 2009;129(4):827\u201333.","journal-title":"J Invest Dermatol"},{"key":"2084_CR121","doi-asserted-by":"crossref","unstructured":"McInnes I Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNF\u03b1. Cytokines as potential therapeutic targets for inflammatory skin diseases, 2006: p. 29\u201344.","DOI":"10.1007\/3-540-37673-9_2"},{"issue":"7","key":"2084_CR122","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/exd.14113","volume":"29","author":"C de Jes\u00fas-Gil","year":"2020","unstructured":"de Jes\u00fas-Gil C, et al. IL-15 and IL-23 synergize to trigger Th17 response by CLA+ T cells in psoriasis. Exp Dermatol. 2020;29(7):630\u20138.","journal-title":"Exp Dermatol"},{"issue":"2","key":"2084_CR123","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/08923970903338367","volume":"32","author":"G Mosayebi","year":"2010","unstructured":"Mosayebi G, et al. Therapeutic effect of EDTA in experimental model of multiple sclerosis. Immunopharmacol Immunotoxicol. 2010;32(2):321\u20136.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"2084_CR124","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5001\/omj.2014.46","volume":"29","author":"D Haghmorad","year":"2014","unstructured":"Haghmorad D, et al. Calcium intervention ameliorates experimental model of multiple sclerosis. Oman Med J. 2014;29(3):185\u20139.","journal-title":"Oman Med J"},{"issue":"18","key":"2084_CR125","doi-asserted-by":"crossref","DOI":"10.3390\/cells13181556","volume":"13","author":"S Dadfar","year":"2024","unstructured":"Dadfar S, et al. The role of mesenchymal stem cells in modulating adaptive immune responses in multiple sclerosis. Cells. 2024;13(18): 1556.","journal-title":"Cells"},{"key":"2084_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/cells13171499","author":"S Gharibi","year":"2024","unstructured":"Gharibi S, et al. Dysregulation of miR-223, miR-146a, and miR-193a expression profile in acute and chronic phases of experimental autoimmune encephalomyelitis in C57BL\/6 mice. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13171499.","journal-title":"Cells"},{"key":"2084_CR127","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000931","author":"C Laurent","year":"2021","unstructured":"Laurent C, et al. Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE. Neurol Neuroimmunol Neuroinflamm. 2021. https:\/\/doi.org\/10.1212\/NXI.0000000000000931.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"2084_CR128","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1179\/016164109X12445616596247","volume":"32","author":"M Rentzos","year":"2010","unstructured":"Rentzos M, et al. Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse. Neurol Res. 2010;32(7):684\u20139.","journal-title":"Neurol Res"},{"issue":"18","key":"2084_CR129","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10184174","volume":"10","author":"MK Zarobkiewicz","year":"2021","unstructured":"Zarobkiewicz MK, et al. IL-15 is overexpressed in \u03b3\u03b4 T cells and correlates with disease severity in relapsing-remitting multiple sclerosis. J Clin Med. 2021;10(18): 4174.","journal-title":"J Clin Med"},{"issue":"3","key":"2084_CR130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41590-024-02073-8","volume":"26","author":"D In\u00e1cio","year":"2025","unstructured":"In\u00e1cio D, et al. Signature cytokine-associated transcriptome analysis of effector \u03b3\u03b4 T cells identifies subset-specific regulators of peripheral activation. Nat Immunol. 2025;26(3):497\u2013510.","journal-title":"Nat Immunol"},{"issue":"10","key":"2084_CR131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nri3896","volume":"15","author":"NR West","year":"2015","unstructured":"West NR, et al. Emerging cytokine networks in colorectal cancer. Nat Rev Immunol. 2015;15(10):615\u201329.","journal-title":"Nat Rev Immunol"},{"key":"2084_CR132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.616853","volume":"12","author":"E Gianchecchi","year":"2021","unstructured":"Gianchecchi E, Delfino DV, Fierabracci A. Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases? Front Immunol. 2021;12: 616853.","journal-title":"Front Immunol"},{"issue":"12","key":"2084_CR133","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/kei083","volume":"44","author":"L Baranda","year":"2005","unstructured":"Baranda L, et al. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Rheumatology. 2005;44(12):1507\u201313.","journal-title":"Rheumatology"},{"issue":"8","key":"2084_CR134","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023;82(8):999\u20131014.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2084_CR135","volume":"2011","author":"K Ohl","year":"2011","unstructured":"Ohl K, Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. BioMed Res Int. 2011;2011(1): 432595.","journal-title":"BioMed Res Int"},{"issue":"22","key":"2084_CR136","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213829","volume":"23","author":"MM Melamud","year":"2022","unstructured":"Melamud MM, et al. Multiplex analysis of serum cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Int J Mol Sci. 2022;23(22): 13829.","journal-title":"Int J Mol Sci"},{"key":"2084_CR137","doi-asserted-by":"crossref","unstructured":"Wang T et al., IL-15 enhances functional properties and responses of cytotoxic CD4+ CD28\u2212 T cells expanded in systemic lupus erythematosus. bioRxiv, 2023: p. 2023.01. 04.522682.","DOI":"10.1101\/2023.01.04.522682"},{"key":"2084_CR138","doi-asserted-by":"crossref","unstructured":"Zuboon H, Mohsin MI, Evaluate Interleukin-15 in SLE patients and its association with hemolytic anemia. Magazine of Al-Kufa University for Biology, 2024. 16(2).","DOI":"10.36320\/ajb\/v16.i2.16840"},{"issue":"1","key":"2084_CR139","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12979-022-00305-9","volume":"19","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. Excessive IL-15 promotes cytotoxic CD4 + CD28\u2212 T cell-mediated renal injury in lupus nephritis. Immunity Ageing. 2022;19(1):50.","journal-title":"Immunity Ageing"},{"issue":"5","key":"2084_CR140","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s10753-023-01860-z","volume":"46","author":"T Wang","year":"2023","unstructured":"Wang T, et al. Coordinated priming of NKG2D pathway by IL-15 enhanced functional properties of cytotoxic CD4+CD28\u2212 T cells expanded in systemic lupus erythematosus. Inflammation. 2023;46(5):1587\u2013601.","journal-title":"Inflammation"},{"key":"2084_CR141","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102615","volume":"119","author":"A Thanou","year":"2021","unstructured":"Thanou A, et al. Clinical disease activity and flare in SLE: current concepts and novel biomarkers. J Autoimmun. 2021;119: 102615.","journal-title":"J Autoimmun"},{"issue":"3","key":"2084_CR142","first-page":"357","volume":"75","author":"T Fujii","year":"2017","unstructured":"Fujii T, Watanabe M. Definition and epidemiology of inflammatory bowel disease. Nihon Rinsho. 2017;75(3):357\u201363.","journal-title":"Nihon Rinsho"},{"issue":"10","key":"2084_CR143","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330(10):951\u201365.","journal-title":"JAMA"},{"issue":"3","key":"2084_CR144","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10396-021-01181-4","volume":"50","author":"T Kamano","year":"2001","unstructured":"Kamano T, et al. Diagnosis of ulcerative colitis and Crohn\u2019s disease using transabdominal ultrasonography. J Med Ultrason. 2001;50(3):313\u20139.","journal-title":"J Med Ultrason"},{"key":"2084_CR145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"YH Chien","year":"2014","unstructured":"Chien YH, Meyer C, Bonneville M. \u03b3\u03b4 T cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121\u201355.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2084_CR146","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, et al. Ulcerative colitis. Nat Rev Dis Primers. 2020;6(1):74.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2084_CR147","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/intimm\/dxz082","volume":"32","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, et al. Intestinal epithelial cell-derived IL-15 determines local maintenance and maturation of intra-epithelial lymphocytes in the intestine. Int Immunol. 2020;32(5):307\u201319.","journal-title":"Int Immunol"},{"issue":"10","key":"2084_CR148","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/eji.200535173","volume":"36","author":"F Obermeier","year":"2006","unstructured":"Obermeier F, et al. IL-15 protects intestinal epithelial cells. Eur J Immunol. 2006;36(10):2691\u20139.","journal-title":"Eur J Immunol"},{"issue":"3","key":"2084_CR149","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030234","volume":"14","author":"V Rotondi Aufiero","year":"2025","unstructured":"Rotondi Aufiero V, et al. Neutralizing IL-15 inhibits tissue-damaging immune response in ex vivo cultured untreated celiac intestinal mucosa. Cells. 2025;14(3): 234.","journal-title":"Cells"},{"key":"2084_CR150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12943-015-0397-y","volume":"14","author":"H Zhang","year":"2015","unstructured":"Zhang H, et al. Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer. Mol Cancer. 2015;14:126.","journal-title":"Mol Cancer"},{"issue":"7","key":"2084_CR151","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/01902148.2016.1235237","volume":"42","author":"K Looi","year":"2016","unstructured":"Looi K, et al. Effect of human rhinovirus infection on airway epithelium tight junction protein disassembly and transepithelial permeability. Exp Lung Res. 2016;42(7):380\u201395.","journal-title":"Exp Lung Res"},{"issue":"37","key":"2084_CR152","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.3748\/wjg.15.4609","volume":"15","author":"D De Nitto","year":"2009","unstructured":"De Nitto D, et al. Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World J Gastroenterol. 2009;15(37):4609\u201314.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2084_CR153","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/14712598.2019.1652267","volume":"19","author":"I Marafini","year":"2019","unstructured":"Marafini I, et al. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opin Biol Ther. 2019;19(11):1207\u201317.","journal-title":"Expert Opin Biol Ther"},{"key":"2084_CR154","doi-asserted-by":"crossref","unstructured":"Ulas ST et al. New bone formation in axial spondyloarthritis: a review. in R\u00f6Fo-Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren. 2024. Georg Thieme Verlag KG.","DOI":"10.1055\/a-2193-1970"},{"issue":"7","key":"2084_CR155","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301508RRR","volume":"38","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, et al. Exercise and osteoimmunology in bone remodeling. FASEB J. 2024;38(7): e23554.","journal-title":"FASEB J"},{"issue":"7","key":"2084_CR156","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/jcp.31036","volume":"238","author":"A Anwar","year":"2023","unstructured":"Anwar A, et al. Fine-tuning osteoclastogenesis: an insight into the cellular and molecular regulation of osteoclastogenesis. J Cell Physiol. 2023;238(7):1431\u201364.","journal-title":"J Cell Physiol"},{"issue":"7","key":"2084_CR157","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/08820139.2013.822766","volume":"42","author":"PP Souza","year":"2013","unstructured":"Souza PP, Lerner UH. The role of cytokines in inflammatory bone loss. Immunol Invest. 2013;42(7):555\u2013622.","journal-title":"Immunol Invest"},{"issue":"1","key":"2084_CR158","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu W, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone research. 2019;7(1):22.","journal-title":"Bone research"},{"key":"2084_CR159","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.imlet.2017.08.010","volume":"190","author":"TO Robinson","year":"2017","unstructured":"Robinson TO, Schluns KS. The potential and promise of IL-15 in immuno-oncogenic therapies. Immunol Lett. 2017;190:159\u201368.","journal-title":"Immunol Lett"},{"issue":"4","key":"2084_CR160","first-page":"291","volume":"31","author":"Y Rodr\u00edguez-\u00c1lvarez","year":"2014","unstructured":"Rodr\u00edguez-\u00c1lvarez Y, et al. Application of a colorimetric CTLL-2 cell proliferation assay for the evaluation of IL-15 antagonists. Biotecnol Apl. 2014;31(4):291\u20136.","journal-title":"Biotecnol Apl"},{"issue":"12","key":"2084_CR161","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","volume":"4","author":"M-L L\u00e4hdeaho","year":"2019","unstructured":"L\u00e4hdeaho M-L, et al. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study. Lancet Gastroenterol Hepatol. 2019;4(12):948\u201359.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"15","key":"2084_CR162","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.2022017643","volume":"142","author":"JE Brammer","year":"2023","unstructured":"Brammer JE, et al. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia. Blood. 2023;142(15):1271\u201380.","journal-title":"Blood"},{"key":"2084_CR163","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2019.11.011","volume":"117","author":"JC Nolz","year":"2020","unstructured":"Nolz JC, Richer MJ. Control of memory CD8+ T cell longevity and effector functions by IL-15. Mol Immunol. 2020;117:180\u20138.","journal-title":"Mol Immunol"},{"issue":"52","key":"2084_CR164","doi-asserted-by":"crossref","first-page":"20024","DOI":"10.1074\/jbc.RA119.010740","volume":"294","author":"W Wong","year":"2019","unstructured":"Wong W, et al. The exercise cytokine interleukin-15 rescues slow wound healing in aged mice. J Biol Chem. 2019;294(52):20024\u201338.","journal-title":"J Biol Chem"},{"key":"2084_CR165","doi-asserted-by":"crossref","first-page":"1040669","DOI":"10.3389\/fimmu.2022.1040669","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, et al. ALT-803 in the treatment of non-muscle-invasive bladder cancer: preclinical and clinical evidence and translational potential. Front Immunol. 2022;13:1040669.","journal-title":"Front Immunol"},{"issue":"5","key":"2084_CR166","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S1470-2045(18)30148-7","volume":"19","author":"JM Wrangle","year":"2018","unstructured":"Wrangle JM, et al. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018;19(5):694\u2013704.","journal-title":"Lancet Oncol"},{"key":"2084_CR167","doi-asserted-by":"crossref","unstructured":"Peng K, Y-X Fu, Y Liang, Engineering cytokines for tumor-targeting and selective T cell activation. Trends in Molecular Medicine, 2025.","DOI":"10.1016\/j.molmed.2025.01.010"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02084-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:55:06Z","timestamp":1767200106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02084-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02084-7","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"141"}}